← Leaderboards
Matt Monarski
Spinal Singularity, Inc.
$742,455
Attributed
$742,455
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$742,455 · 1
By mechanism
R44$742,455 · 1
Top collaborators
No co-investigators on record.
Most similar at Spinal Singularity, Inc.
Same institution · by research overlap
- Derek Herrera$225,000
- William Colone$746,161
Others in their field
Other Emerging Leaders on “Bacteria”
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Gary Fanger · Rise Therapeutics, Llc$19,697,313
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$14,299,891
Research focus
BacteriaBaseBiomaterial CompatibilityBladderCatheter Associated UtiCatheterizationCathetersCessation Of LifeChronicClinical ProtocolsClinical ResearchClinical Research SiteClinical TrialsCostData CollectionDesignDevicesDistalDrainage ProcedureEffectivenessEnrollmentEquipment And Supply InventoriesExcisionAccounting